Merck (MRK) Change in Acquisitions & Divestments (2009 - 2025)
Merck (MRK) reported Change in Acquisitions & Divestments of $46.0 million for Q4 2025, up 112.43% year-over-year from $21.7 million in Q4 2024, and down 92.0% on a QoQ basis from $575.0 million in Q3 2025.
Merck (MRK) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $46.0 million in Q4 2025.
- Quarterly Change in Acquisitions & Divestments rose 112.43% year-over-year to $46.0 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 523.47% YoY) and the FY2025 annual result came in at $1.7 billion, changed N/A from the prior year.
- Change in Acquisitions & Divestments retreated to $46.0 million in Q4 2025 per MRK's latest filing, from $575.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $704.0 million in Q3 2023 and bottomed at -$370.0 million in Q4 2024.
- The 5-year median for Change in Acquisitions & Divestments is $285.0 million (2023), against an average of $267.5 million.
- The widest annual swing landed in 2023, when Change in Acquisitions & Divestments surged 49900.0%; it then tumbled 318.93% in 2024.
- Tracing MRK's Change in Acquisitions & Divestments over 5 years: stood at $529.0 million in 2021, then slumped by 97.73% to $12.0 million in 2022, then soared by 1308.33% to $169.0 million in 2023, then plunged by 318.93% to -$370.0 million in 2024, then soared by 112.43% to $46.0 million in 2025.
- Per Business Quant, the three latest MRK Change in Acquisitions & Divestments figures stand at $46.0 million (Q4 2025), $575.0 million (Q3 2025), and $601.0 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.00 Mn |
| Dec 31, 2025 | 46.00 Mn |
| Sep 30, 2025 | 575.00 Mn |
| Sep 30, 2025 | 575.00 Mn |
| Jun 30, 2025 | 601.00 Mn |
| Jun 30, 2025 | 601.00 Mn |
| Mar 31, 2025 | 456.00 Mn |
| Mar 31, 2025 | 456.00 Mn |
| Dec 31, 2024 | -370.00 Mn |
| Dec 31, 2024 | -370.00 Mn |
| Sep 30, 2024 | 50.00 Mn |
| Sep 30, 2024 | 50.00 Mn |
| Jun 30, 2024 | 60.00 Mn |
| Jun 30, 2024 | 60.00 Mn |
| Mar 31, 2024 | 260.00 Mn |
| Mar 31, 2024 | 260.00 Mn |
| Dec 31, 2023 | 169.00 Mn |
| Dec 31, 2023 | 169.00 Mn |
| Sep 30, 2023 | 704.00 Mn |
| Sep 30, 2023 | 704.00 Mn |
| Jun 30, 2023 | 285.00 Mn |
| Jun 30, 2023 | 285.00 Mn |
| Mar 31, 2023 | 500.00 Mn |
| Mar 31, 2023 | 500.00 Mn |
| Dec 31, 2022 | 12.00 Mn |
| Dec 31, 2022 | 12.00 Mn |
| Sep 30, 2022 | 335.00 Mn |
| Sep 30, 2022 | 335.00 Mn |
| Jun 30, 2022 | 373.00 Mn |
| Jun 30, 2022 | 373.00 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 529.00 Mn |
| Dec 31, 2021 | 529.00 Mn |
| Sep 30, 2021 | 111.00 Mn |
| Sep 30, 2021 | 111.00 Mn |
| Mar 31, 2021 | 386.00 Mn |
| Mar 31, 2021 | 386.00 Mn |
| Dec 31, 2020 | 918.00 Mn |
| Dec 31, 2020 | 918.00 Mn |
| Sep 30, 2020 | 2.00 Mn |
| Sep 30, 2020 | 2.00 Mn |
| Jun 30, 2020 | 76.00 Mn |
| Jun 30, 2020 | 76.00 Mn |
| Mar 31, 2020 | 1.82 Bn |
| Mar 31, 2020 | 1.82 Bn |
| Dec 31, 2019 | 1.16 Bn |
| Dec 31, 2019 | 1.16 Bn |
| Sep 30, 2019 | 2.52 Bn |
| Sep 30, 2019 | 2.52 Bn |
| Jun 30, 2019 | 3.04 Bn |
| Jun 30, 2019 | 3.04 Bn |
| Mar 31, 2019 | 1.90 Bn |
| Mar 31, 2019 | 1.90 Bn |
| Dec 31, 2018 | 4.01 Bn |
| Dec 31, 2018 | 4.01 Bn |
| Sep 30, 2018 | 3.84 Bn |
| Sep 30, 2018 | 3.84 Bn |
| Jun 30, 2018 | 5.56 Bn |
| Jun 30, 2018 | 5.56 Bn |
| Mar 31, 2018 | 1.85 Bn |
| Mar 31, 2018 | 1.85 Bn |
| Dec 31, 2017 | 3.13 Bn |
| Dec 31, 2017 | 3.13 Bn |
| Sep 30, 2017 | 3.17 Bn |
| Sep 30, 2017 | 3.17 Bn |
| Jun 30, 2017 | 2.54 Bn |
| Jun 30, 2017 | 2.54 Bn |
| Mar 31, 2017 | 6.82 Bn |
| Mar 31, 2017 | 6.82 Bn |
| Dec 31, 2016 | 3.05 Bn |
| Dec 31, 2016 | 3.05 Bn |
| Sep 30, 2016 | 3.91 Bn |
| Sep 30, 2016 | 3.91 Bn |
| Jun 30, 2016 | 2.77 Bn |
| Jun 30, 2016 | 2.77 Bn |
| Mar 31, 2016 | 4.62 Bn |
| Mar 31, 2016 | 4.62 Bn |
| Dec 31, 2015 | 3.88 Bn |
| Dec 31, 2015 | 3.88 Bn |
| Sep 30, 2015 | 3.90 Bn |
| Sep 30, 2015 | 3.90 Bn |
| Jun 30, 2015 | 6.34 Bn |
| Jun 30, 2015 | 6.34 Bn |
| Mar 31, 2015 | 6.29 Bn |
| Mar 31, 2015 | 6.29 Bn |
| Dec 31, 2014 | 3.31 Bn |
| Dec 31, 2014 | 3.31 Bn |
| Sep 30, 2014 | 3.71 Bn |
| Sep 30, 2014 | 3.71 Bn |
| Jun 30, 2014 | 5.47 Bn |
| Jun 30, 2014 | 5.47 Bn |
| Mar 31, 2014 | 2.63 Bn |
| Mar 31, 2014 | 2.63 Bn |
| Dec 31, 2013 | 6.48 Bn |
| Dec 31, 2013 | 6.48 Bn |
| Sep 30, 2013 | 2.63 Bn |
| Sep 30, 2013 | 2.63 Bn |
| Jun 30, 2013 | 4.03 Bn |
| Jun 30, 2013 | 4.03 Bn |
| Mar 31, 2013 | 3.16 Bn |
| Mar 31, 2013 | 3.16 Bn |
| Dec 31, 2012 | 2.18 Bn |
| Dec 31, 2012 | 2.18 Bn |
| Sep 30, 2012 | 1.43 Bn |
| Sep 30, 2012 | 1.43 Bn |
| Jun 30, 2012 | 1.38 Bn |
| Jun 30, 2012 | 1.38 Bn |
| Mar 31, 2012 | 2.80 Bn |
| Mar 31, 2012 | 2.80 Bn |
| Dec 31, 2011 | 1.41 Bn |
| Dec 31, 2011 | 1.41 Bn |
| Sep 30, 2011 | 1.85 Bn |
| Sep 30, 2011 | 1.85 Bn |
| Jun 30, 2011 | 1.37 Bn |
| Jun 30, 2011 | 1.37 Bn |
| Mar 31, 2011 | 1.52 Bn |
| Mar 31, 2011 | 1.52 Bn |
| Dec 31, 2010 | 835.00 Mn |
| Dec 31, 2010 | 835.00 Mn |
| Sep 30, 2010 | 2.03 Bn |
| Sep 30, 2010 | 2.03 Bn |
| Jun 30, 2010 | 1.43 Bn |
| Jun 30, 2010 | 1.43 Bn |
| Mar 31, 2010 | 273.00 Mn |
| Mar 31, 2010 | 273.00 Mn |
| Dec 31, 2009 | 596.30 Mn |
| Dec 31, 2009 | 596.30 Mn |
| Sep 30, 2009 | 4.51 Bn |
| Sep 30, 2009 | 4.51 Bn |
| Jun 30, 2009 | 2.72 Bn |
| Jun 30, 2009 | 2.72 Bn |
| Mar 31, 2009 | 3.12 Bn |
| Mar 31, 2009 | 3.12 Bn |